Wednesday, July 27, 2022

Someone Named Eleanor Warnock Perfectly... Nailed The Monday Martin Shkreli Announcement...


I am mostly off-grid with family fun this week, to next Wednesday. . . but I will reproduce her tweet (albeit slightly delayed), at right. Flawless. Simply. . . flawless.

And for those who still don't get it, I quote our erstwhile anon. commenter (at another property), who quotes the injunction at page 3:

. . .“Development” means all preclinical and clinical research and development activities related to a Drug Product, including discovery or identification of a new chemical entity, test method development, all studies for the safety and efficacy of a Drug Product, toxicology studies, bioequivalence and bioavailability studies, pharmaceutical formulation, process development, manufacturing scale-up, development-stage manufacturing, quality assurance/quality control development, stability testing, statistical analysis and report writing, for the purpose of obtaining any and all FDA Authorizations, licenses, approvals, or registrations necessary for the manufacture, use, storage, import, export, transport, promotion, marketing, and sale of a Drug Product, and regulatory affairs related to the foregoing. . . .”

Entity is defined as “means any partnership, joint venture, firm, corporation, association, trust, unincorporated organization, or other business or government entity, and any subsidiaries, divisions, groups, or affiliates thereof. . . .”


So it goes. He has literally no path to bring this lawfully -- to any investor.

Out -- grinning.

नमस्ते

No comments: